Literature DB >> 18171263

Chlorhexidine: expanding the armamentarium for infection control and prevention.

Aaron M Milstone1, Catherine L Passaretti, Trish M Perl.   

Abstract

Health care-associated infections (HAIs) result in increased patient morbidity and utilization of health care resources. Rates of HAI are increasing despite advances in health care technology. Limited antimicrobial agents and a dry drug pipeline make novel prevention efforts critical. Chlorhexidine, an antiseptic solution that has been used worldwide since the 1950s, is a safe and effective product with broad antiseptic activity. Novel uses of chlorhexidine-containing products are being implemented to promote antisepsis and prevent bacterial colonization and infection. We review some of the many infection control applications of chlorhexidine in the battle against HAI, such as general skin cleansing, skin decolonization, preoperative showering and bathing, vascular catheter site preparation, impregnated catheter site dressings, impregnated catheters, and oral decontamination. As mandatory public reporting and pay for performance force infection control issues to the forefront, chlorhexidine-containing products may provide a vast armamentarium for the control and prevention of HAI.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18171263     DOI: 10.1086/524736

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  89 in total

1.  Reducing surgical site infections: a review.

Authors:  David E Reichman; James A Greenberg
Journal:  Rev Obstet Gynecol       Date:  2009

2.  What's new in catheter-related infection: skin cleansing and skin antisepsis.

Authors:  Olivier Mimoz; Vineet Chopra; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2016-02-03       Impact factor: 17.440

3.  Effects of daily bathing with chlorhexidine and acquired infection of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus: a meta-analysis.

Authors:  Wensen Chen; Songqin Li; Lianhong Li; Xin Wu; Weihong Zhang
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

Review 4.  Prevention of Recurrent Staphylococcal Skin Infections.

Authors:  C Buddy Creech; Duha N Al-Zubeidi; Stephanie A Fritz
Journal:  Infect Dis Clin North Am       Date:  2015-09       Impact factor: 5.982

5.  Reduction of central venous line-associated bloodstream infection rates by using a chlorhexidine-containing dressing.

Authors:  S Scheithauer; K Lewalter; J Schröder; A Koch; H Häfner; V Krizanovic; K Nowicki; R-D Hilgers; S W Lemmen
Journal:  Infection       Date:  2013-08-09       Impact factor: 3.553

Review 6.  Antimicrobial Resistance to Agents Used for Staphylococcus aureus Decolonization: Is There a Reason for Concern?

Authors:  Gregory R Madden; Costi D Sifri
Journal:  Curr Infect Dis Rep       Date:  2018-06-07       Impact factor: 3.725

7.  Contribution of interfacility patient movement to overall methicillin-resistant Staphylococcus aureus prevalence levels.

Authors:  Sean L Barnes; Anthony D Harris; Bruce L Golden; Edward A Wasil; Jon P Furuno
Journal:  Infect Control Hosp Epidemiol       Date:  2011-10-03       Impact factor: 3.254

8.  Antiseptic Agents Elicit Short-Term, Personalized, and Body Site-Specific Shifts in Resident Skin Bacterial Communities.

Authors:  Adam J SanMiguel; Jacquelyn S Meisel; Joseph Horwinski; Qi Zheng; Charles W Bradley; Elizabeth A Grice
Journal:  J Invest Dermatol       Date:  2018-05-09       Impact factor: 8.551

9.  Implementation of daily chlorhexidine bathing to reduce colonization by multidrug-resistant organisms in a critical care unit.

Authors:  Jackson S Musuuza; Ajay K Sethi; Tonya J Roberts; Nasia Safdar
Journal:  Am J Infect Control       Date:  2017-04-18       Impact factor: 2.918

10.  High rate of qacA- and qacB-positive methicillin-resistant Staphylococcus aureus isolates from chlorhexidine-impregnated catheter-related bloodstream infections.

Authors:  Cheng-Mao Ho; Chi-Yuan Li; Mao-Wang Ho; Chien-Yu Lin; Shu-Hui Liu; Jang-Jih Lu
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.